Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. The company develops batoclimab, a novel fully human monoclonal antibody that target the neonatal fragment crystallizable receptor for the treatment of myasthenia gravis, thyroid eye disease, chronic inflammatory demyelinating polyneuropathy, Graves diseases, and warm autoimmune hemolytic anemia. Immunovant, Inc. is based in New York, New York. Immunovant, Inc. is a subsidiary of Roivant Sciences Ltd.

Immunovant, Inc.

Insiders have been trading these 5 stocks: (($IMVT)), (($HP)), (($SN)), (($PBF)) and (($VG)). Here is a breakdown of their recent trades and their ...

Insiders Cash Out at Immunovant, Helmerich & Payne, SharkNinja, PBF Energy, Venture Global

Insiders have been trading these 5 stocks: (($LRMR)), (($CYTK)), (($ITUB)), (($GLBE)) and (($IMVT)). Here is a breakdown of their recent trades and...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	IMVT	$39.95	+0.53%	906.30K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	IMVT	$39.95	+0.5%	906.30K
3
4
5
6

IMVT

IMVT

Get Immunovant, Inc. Data in Excel

Get Immunovant, Inc. Data in Excel